Abstract:Objective To explore the expression of the TGF-β1 of diabetic foot wound granulation tissue treated by negative pressure wound therapy (NPWT),which with mild or moderate peripheral artery disease.Methods Forty three patients at Bethune International Peace Hospital of People's Liberation Army with diabetic foot ulcers from January 2014 to February 2018 were enrolled in this study and divided into moderate ischemia group [23 cases,0.5 ≤ ankle-brachial index (ABI) ＜ 0.7] and mild ischemia group (20 cases,0.7 ≤ ABI ＜ 0.9) according to the ABI.Granulation tissue biopsies were taken before and 14 days after treatment,which were all divided into three parts:one part were preserved in 4％ paraformaldehyde at 4 ℃ for immunohistochemical staining when all specimens collected;the other two parts were transferred in liquid nitrogen to the laboratory immediately and preserved in refrigerator at-80 ℃ for Western blotting and Real-time PCR respectively.Date were compared with independent sample t test.Result Immunohistochemical staining showed that optical density of TGF-β1 after 14 days treatment in both moderate and mild ischemia group were higher than those before treatment,the differences were statistically significant (with P values below 0.05),with the increase in mild ischemia group (63.09 ± 10.96) ％ more significant than moderate ischemia group [(38.71 ± 12.78) ％],the difference was statistically significant (t =-6.66,P ＜ 0.05).Western blotting showed those the expression of TGF-β1 protein after 14 days treatment were higher than that before treatment in both moderate and mild ischemia group,the differences were statistically significant (with P values below 0.05),compared with the increase in mild ischemia group (50.31 ± 25.64)％,the degree of change in the mild ischemic group [(85.44 ± 27.78)％] was significant,the difference was statistically significant (t =-4.31,P ＜ 0.05).Real-time PCR showed that the expression of TGF-β1 gene after 14 days treatment were higher than those before treatment in both moderate and mild ischemia group,the differences were statistically significant (with P values below 0.05).Compared with the change amplitude of the moderate ischemic groups [(73.85 ± 41.22)％],the increase the mild ischemic group [(129.78 ± 36.71)％] was significant,the difference was statistically significant (t =-4.67,P ＜ 0.05).Conclusion NPWT can promote the expression of TGF-β1 in granulation tissue of diabetic patients with mild and moderate ischemic wounds,moreover,the promotion of TGF-β1 expression in granulation tissue of diabetic foot with mild ischemic wound is better than that of moderate ischemic wound.

Research progress of wound surface repair of diabetic feet by transforming growth factor-β and its receptor

Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects

Baicalin Derivative Dynamically Cross-Linked Natural Polysaccharide Hydrogel for Diabetic Wound Healing

Growth factors in the pathogenesis of diabetic foot ulcers.

Research progress on and molecular mechanism of vacuum sealing drainage in the treatment of diabetic foot ulcers

Effect of Negative Pressure Wound Therapy on Cellular Fibronectin and Transforming Growth Factor-β1 Expression in Diabetic Foot Wounds.

Tibial transverse transport promotes wound healing in diabetic foot ulcers by stimulating endothelial progenitor cell mobilization and homing mediated neovascularization

Impact of tibial transverse transport in tissue regeneration and wound healing with perspective on diabetic foot ulcers

Effect of Negative Pressure Wound Therapy on the Expression of Transforming Growth Factor-Beta1 in Granulation Tissue with Mild and Moderate Ischemia Wound of Diabetic Foot

Analysis of mRNA expression profile in the treatment of diabetic foot ulcer healing by tibial cortex transverse distraction

WDR74 facilitates TGF-β/Smad pathway activation to promote M2 macrophage polarization and diabetic foot ulcer wound healing in mice

Growth differentiation factor 10 induces angiogenesis to promote wound healing in rats with diabetic foot ulcers by activating TGF-β1/Smad3 signaling pathway

Preparation of a Dual-Functional Sulfated Galactofucan Polysaccharide/Poly(vinyl alcohol) Hydrogel to Promote Macrophage Recruitment and Angiogenic Potential in Diabetic Wound Healing

Impact of Negative Pressure Wound Therapy on Basic Fibroblast Growth Factor in Human Diabetic Foot Wounds

Research progress and application prospect of adipose-derived stem cell secretome in diabetes foot ulcers healing

Bone transport induces the release of factors with multi-tissue regenerative potential for diabetic wound healing in rats and patients

Research advances in hydrogel-based wound dressings for diabetic foot ulcer treatment: a review

Advancements in diabetic foot ulcer research: Focus on mesenchymal stem cells and their exosomes

Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds

Improving Chronic Diabetic Wound Healing through an Injectable and Self-Healing Hydrogel with Platelet-Rich Plasma Release

Tibial cortex transverse transport potentiates diabetic wound healing via activation of SDF-1/CXCR4 signaling